Peptide-drug Conjugate Information
General Information of This Peptide-drug Conjugate (PDC)
| PDC ID |
PDC_02124
|
|||||
|---|---|---|---|---|---|---|
| PDC Name |
Gefitinib LARLLT conjugate e
|
|||||
| PDC Status |
Investigative
|
|||||
| Structure |
|
|||||
| Peptide Name |
D4
|
Peptide Info | ||||
| Receptor Name |
Pro-epidermal growth factor (EGF)
|
Receptor Info | ||||
| Drug Name |
Gefitinib
|
Drug Info | ||||
| Therapeutic Target |
Epidermal growth factor receptor (EGFR)
|
Target Info | ||||
| Linker Name |
Suberic acid
|
Linker Info | ||||
| Formula |
C61H94ClFN14O12
|
|||||
| #Ro5 Violations (Lipinski): 4 | Molecular Weight | 1269.96 | ||||
| Lipid-water partition coefficient (xlogp) | 4.0142 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 11 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 16 | |||||
| Rotatable Bond Count (rotbonds) | 39 | |||||